AU4613796A - Medicament in particle form - Google Patents

Medicament in particle form

Info

Publication number
AU4613796A
AU4613796A AU46137/96A AU4613796A AU4613796A AU 4613796 A AU4613796 A AU 4613796A AU 46137/96 A AU46137/96 A AU 46137/96A AU 4613796 A AU4613796 A AU 4613796A AU 4613796 A AU4613796 A AU 4613796A
Authority
AU
Australia
Prior art keywords
medicament
particle form
particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46137/96A
Inventor
Serap Atmaca-Abdel Aziz
Jorg Kreuter
Christian Noe
Frank Stieneker
Andreas Zimmer
Hans-Peter Zobel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4613796A publication Critical patent/AU4613796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
AU46137/96A 1995-02-10 1996-02-12 Medicament in particle form Abandoned AU4613796A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AT24895 1995-02-10
AT248/95 1995-02-10
AT23696 1996-02-09
AT236/96 1996-02-09
PCT/AT1996/000023 WO1996024377A1 (en) 1995-02-10 1996-02-12 Medicament in particle form

Publications (1)

Publication Number Publication Date
AU4613796A true AU4613796A (en) 1996-08-27

Family

ID=25591973

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46137/96A Abandoned AU4613796A (en) 1995-02-10 1996-02-12 Medicament in particle form

Country Status (5)

Country Link
EP (1) EP0808174B1 (en)
JP (1) JPH11511731A (en)
AU (1) AU4613796A (en)
DE (1) DE59610423D1 (en)
WO (1) WO1996024377A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59707744D1 (en) * 1996-10-23 2002-08-22 Sueddeutsche Kalkstickstoff METHOD FOR PRODUCING BIOLOGICALLY ACTIVE POLYMERNANOPARTICLE-NUCLEIC ACID CONJUGATES
EP1374908A3 (en) * 1998-10-09 2004-03-24 The Regents Of The University Of Michigan Polymer-drug conjugates comprising hydrazide linkers
US6867275B2 (en) 2001-03-30 2005-03-15 Rohm And Haas Company Solid media
FR2841137B1 (en) * 2002-06-20 2004-08-13 Bioalliance Pharma VECTORIZATION SYSTEM COMPRISING HOMOGENEOUS SIZE NANOPARTICLES OF AT LEAST ONE POLYMER AND AT LEAST ONE POSITIVELY CHARGED POLYSACCHARIDE
WO2005097197A1 (en) * 2004-04-05 2005-10-20 Basf Aktiengesellschaft Polymer particles containing active agents
WO2007036494A2 (en) * 2005-09-30 2007-04-05 Basf Se Agrochemical formulation comprising polymer particles containing active substances

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59140202A (en) * 1983-01-31 1984-08-11 Sumitomo Chem Co Ltd Production of spherical polymer particles
AU578275B2 (en) * 1984-03-01 1988-10-20 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Pharmaceutical compositions
SE468814B (en) * 1991-07-22 1993-03-22 Inovata Ab PROCEDURES FOR BINDING A SOCIETY CONTAINING A NUCLEPHILE GROUP TO AN AMINE AND / OR HYDROXYGRAPHIC POLYMER
AT407639B (en) * 1993-12-13 2001-05-25 Christian Dr Noe MODIFIED OLIGONUCLEOTIDS, METHOD FOR THE PRODUCTION THEREOF AND USE AS ACTIVE SUBSTANCES FOR THE PRODUCTION OF MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
EP0808174B1 (en) 2003-05-07
JPH11511731A (en) 1999-10-12
EP0808174A1 (en) 1997-11-26
DE59610423D1 (en) 2003-06-12
WO1996024377A1 (en) 1996-08-15

Similar Documents

Publication Publication Date Title
AU3229095A (en) Particle delivery
AU3703895A (en) Particle delivery
AU703128B2 (en) Device in inhalers
GB9502879D0 (en) Particle delivery
AUPN411195A0 (en) Medicinal composition
AU3560495A (en) Medicament inhaler
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU7590096A (en) Drug composition
AU5155096A (en) Pharmaceutical composition
AU6128896A (en) Isoindole derivatives, their preparation and their application in therapy
AU4613796A (en) Medicament in particle form
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU5188296A (en) Carbopeptoids and carbonucleotoids
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
AU2172097A (en) Infusion packages and methods for their manufacture
AUPN235195A0 (en) Improvements in artificial surfaces
AU6470996A (en) 4a-aryldecahydroisoquinoline compounds and medicinal uses thereof
AUPN306295A0 (en) Improvements in prosthesis
AU6814496A (en) Pharmaceutical composition
AU7423196A (en) Improvements in cots
AU5261596A (en) Improvements in artificial surfaces
AUPN456695A0 (en) Improvements in syringes
AU4461396A (en) Medicament container
AU4585496A (en) Improvements in steps
AUPN368795A0 (en) All in one - sanitiser - katalyst